BriaCell Announces New Patent Issuance, Bria-OTS IND Timing Guidance, and Additional Clinical Sites to Boost Enrolment Pharmaceutical Investing
Merck Named One of America's Most JUST Companies by JUST Capital and CNBC, Industry Leader in Pharmaceuticals and Biotech Life Science Investing
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets Pharmaceutical Investing
QULIPTA Now Approved by Health Canada for the Preventive Treatment of Episodic Migraine in Adults Pharmaceutical Investing
Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation Pharmaceutical Investing
AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE NAMMI THERAPEUTICS TO RECEIVE THE THIRD AMGEN GOLDEN TICKET Market News
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets Pharmaceutical Investing
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer's 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children Life Science Investing
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results Pharmaceutical Investing
How Merck Is Prioritizing Diversity in Clinical Trials and Why It's So Important Life Science Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
